Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome

1. Verfasser:
Weitere Verfasser: ; ; ; ;
In: Cardiovasc Diabetol, 10(2011), 1, S. 7
Format: E-Artikel
Sprache: Unbestimmt
veröffentlicht: Springer Nature
Schlagworte:
ISSN: 1475-2840
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
finc.format ElectronicArticle
finc.mega_collection Springer Nature (CrossRef)
finc.id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNDc1LTI4NDAtMTAtNw
finc.source_id 49
ris.type EJOUR
rft.atitle Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome
rft.epage 0
rft.genre article
rft.issn 1475-2840
rft.issue 1
rft.jtitle Cardiovasc Diabetol
rft.tpages 0
rft.pages 7
rft.pub Springer Nature
rft.date 2011-01-01
x.date 2011-01-01T00:00:00Z
rft.spage 0
rft.volume 10
authors Hansen Barbara C
Tigno Xenia T
Bénardeau Agnes
Meyer Markus
Sebokova Elena
Mizrahi Jacques
doi 10.1186/1475-2840-10-7
languages und
url http://dx.doi.org/10.1186/1475-2840-10-7
version 0.9
x.subjects Endocrinology, Diabetes and Metabolism
Cardiology and Cardiovascular Medicine
x.type journal-article
x.oa 1